Sintx Technologies, Inc. (SINT) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US8293927039

Price
1.35 USD
Market cap
10.17 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Sintx Technologies, Inc. financials

Fiscal year2025
Revenue1.02 m USD
Gross profit461,000.00 USD
Operating income-10.72 m USD
EBIT-10.36 m USD
Net income-10.36 m USD
Diluted EPS – continuing operations-6.16 USD

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Sintx Technologies, Inc.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.